Fact checked by Nick Blackmer About the Author Patricia Mikula, PharmD, has over nine years of experience and works as an inpatient clinical pharmacist for medical/surgical and intensive care unit ...

Panaji: Mohit was seven years old when he was diagnosed with asthma. He suffered recurrent coughs and colds, chest tightness, ...

DEAR DR. ROACH: I read your column on asthma regarding inhalers. I have tried Spiriva, Advair, Symbicort and an oral pill, which I cannot remember the name of. All of these caused the same side ...

Dear Dr. Roach: I read your column on asthma regarding inhalers. I have tried Spiriva, Advair, Symbicort and an oral pill, which I cannot remember the name of. All of these caused the same side ...

President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of ...

The first generic asthma inhaler, a version of ProAir HFA Inhalation Aerosol, has been approved by the FDA. Doctors say it will lead to a lower price.

More than one quarter of asthma patients have been prescribed potentially dangerous amounts of steroid tablets, with researchers warning this puts them at greater risk of serious side-effects.

FDA officials say the potential for serious side effects from Singulair includes mental health issues such as suicidal thoughts.

Dear Dr. Roach • I read your column on asthma regarding inhalers. I have tried Spiriva, Advair, Symbicort and an oral pill, which I cannot remember the name of.

An inactive agent, used in inhalers to treat asthma, can reverse the beneficial anti-inflammatory effects of inhaled steroids, according to a study presented at the annual meeting of the American ...

Inhalation parameters recorded by a digital asthma device can be used to indicate inhaler technique deterioration, which often wanes soon after patients receive training, researchers reported at ...

AstraZeneca already markets an asthma inhaler. Symbicort, which accounted for more than $2.7 billion in 2021 revenue, administers a combination of the drugs budesonide and formoterol.